University of California San Francisco, Medical Center at Paranassus — San Francisco, California

University of California San Francisco, Medical Center at Paranassus is a clinical research site located in San Francisco, California, United States 94117.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

University of California San Francisco, Medical Center at Paranassus has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma.

Sponsors: Loxo Oncology, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Francisco, Medical Center at Paranassus?

University of California San Francisco, Medical Center at Paranassus has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Francisco, Medical Center at Paranassus conducted?

University of California San Francisco, Medical Center at Paranassus has 2 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma.

Is University of California San Francisco, Medical Center at Paranassus accredited by Crixeo Health?

University of California San Francisco, Medical Center at Paranassus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Francisco, Medical Center at Paranassus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.